ScrutarSign up free

CHURCH & DWIGHT CO INC /DE/ (CHD)

SEC filings, insider trading & institutional ownership from EDGAR.

NYSEMaterialsChemicals

Church & Dwight, founded in 1846 and incorporated in Delaware in 1925, develops, manufactures and markets a broad portfolio of consumer household and personal care products alongside specialty products for animal and food production, chemicals and cleaners. The company operates through three segments: Consumer Domestic, Consumer International and the Specialty Products Division (SPD). Its portfolio includes seven "power brands"—ARM & HAMMER, OXICLEAN, VITAFUSION/L'IL CRITTERS, BATISTE, WATERPIK, THERABREATH and HERO—which together represent approximately 70% of net sales and profits, alongside other well-known names such as TROJAN, NAIR, ORAJEL, FIRST RESPONSE, SPINBRUSH, XTRA and ZICAM.

In Consumer Domestic, household products (about 42% of consolidated net sales) include baking soda-based items, laundry detergents and cat litter, while personal care products (about 36% of consolidated net sales) span oral care, antiperspirants, condoms, dietary supplements, hair care and more. Consumer International, representing about 17% of net sales, markets products through subsidiaries in Australia, Canada, France, Germany, Mexico and the UK, plus exports to over 130 countries via a Global Markets Group. SPD, roughly 5% of net sales, focuses on animal and food production nutritional supplements, specialty chemicals (notably sodium bicarbonate manufactured from trona reserves via a partnership with Tata Chemicals) and specialty cleaners, including joint ventures Armand Products Company and ARMAKLEEN.

Products are distributed through supermarkets, mass merchandisers, clubs, drugstores, e-commerce and other retail channels domestically, and through subsidiary sales teams and distributor networks internationally, with Walmart representing approximately 23% of 2023 consolidated net sales. The company competes against major players including P&G, Clorox, Colgate-Palmolive, Reckitt Benckiser, Unilever and others, many with greater financial resources. Church & Dwight emphasizes a sustainability strategy built around six ESG pillars covering brands, products, packaging, employees/communities, environment/climate, and responsible sourcing, overseen by a Corporate Issues Council and its Board of Directors.

Its operations and products are subject to extensive regulation by agencies including the FDA, EPA, FTC, CPSC and FCC, covering medical devices, OTC pharmaceuticals, dietary supplements, cosmetics and food/animal feed products, with compliance obligations spanning manufacturing practices, labeling, adverse event reporting and premarket clearances.

AI-summarized from Item 1 (Business) of the company's most recent 10-K filing.

RevenueFY2025
$6.20B
▲ 1.6%YoY
Net incomeFY2025
$736.80M
▲ 25.9%YoY
Diluted EPSFY2025
$3.02
▲ 27.4%YoY
Gross margin
44.7%
▼ 95 bpsYoY
Insider net6 mo
+4.4K
shares11 sells0 buys
Institutions
44
$12.97B held

Financials

As reported to the SEC via XBRL, no adjustments

All financials →
Revenue & net income
$2B$4B$6B$8B
FY2022FY2023FY2024FY2025
RevenueNet income
FY2025 highlightsfrom 10-K
Gross profit$2.77B
Operating income$1.08B
Diluted EPS$3.02
Gross margin44.7%
Net margin11.9%

Latest filings

10-K, 10-Q, 8-K, Form 4 & 13D/G. Sourced directly from SEC EDGAR

All filings →
FormFiledAccession
4Linares Carlos G.Aug 27, 2026EDGAR
4Hemsey ReneAug 26, 2026EDGAR
4Linares Carlos G.Aug 25, 2026EDGAR
4IRWIN BRADLEY CAug 12, 2026EDGAR
4WINKLEBLACK ARTHUR BAug 6, 2026EDGAR
10-QJul 31, 2026EDGAR
8-KJul 31, 2026EDGAR
4Vergis Janet S.Jul 2, 2026EDGAR

Insider trading

From Form 4 filings

All →
InsiderDateType
Linares Carlos G.Aug 26, 2026Sell
Linares Carlos G.Aug 26, 2026Option exercise
Hemsey ReneAug 25, 2026Sell
Hemsey ReneAug 25, 2026Option exercise
Linares Carlos G.Aug 24, 2026Sell

Top holders

13F & 13D/G · latest quarter

All →
HolderFiledValue
BlackRock, Inc.Aug 7, 2026$2.17B
Vanguard Capital ManagementAug 13, 2026$1.50B
STATE STREET CORPAug 7, 2026$1.36B
Vanguard Portfolio ManagementAug 13, 2026$1.27B
JPMORGAN CHASE & COAug 12, 2026$894.86M

CHD's filings are public. The insight is one click away.

Scrutar's AI reads every CHD filing and surfaces what matters. Red flags, risk shifts, disclosure quality and key relationships. Cited to the source, free with an account.

Analyze CHD filingsNo credit cardAI reports included on the free plan

Never miss a CHD filing.

Get an email when CHD files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.

Free foreverNo account requiredOne-click unsubscribe

Protected by reCAPTCHA. Privacy & Terms

Data as of Aug 30, 2026Source: SEC EDGAR.